The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method
- PMID: 2010756
- PMCID: PMC1014294
- DOI: 10.1136/jnnp.54.1.30
The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method
Abstract
Using an unbiased stereological technique, the total numbers of pigmented and non-pigmented neurons were estimated in the substantia nigra of seven patients with Parkinson's disease and seven control patients. Compared with the controls, in which the average total number of pigmented neurons was 550,000, the number of neurons was reduced by 66% in the patients. The average total number of non-pigmented neurons was 260,000 in controls and reduced by 24% in the patients. A significant correlation (r = 0.81) existed between the total numbers of pigmented and non-pigmented neurons in the controls, whereas a similar correlation (r = 0.72) in the patients fell just short of statistical significance. The stereological estimates made in this study are unbiased, in that they are independent of nerve cell size, section thickness and of dimensional changes in brain tissue induced by histological procedures. The stereological method is considerably more efficient than previous conventional methods.
Similar articles
-
Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts.J Neurol Sci. 1997 Oct 3;151(1):83-7. doi: 10.1016/s0022-510x(97)00100-7. J Neurol Sci. 1997. PMID: 9335015
-
Cell counts in the substantia nigra: a comparison of single section counts and disector counts in patients with Parkinson's disease and in controls.Neuropathol Appl Neurobiol. 1995 Feb;21(1):10-7. doi: 10.1111/j.1365-2990.1995.tb01023.x. Neuropathol Appl Neurobiol. 1995. PMID: 7770115
-
Mean volume of pigmented neurons in the substantia nigra in Parkinson's disease.Acta Neurol Scand Suppl. 1992;137:37-9. doi: 10.1111/j.1600-0404.1992.tb05036.x. Acta Neurol Scand Suppl. 1992. PMID: 1414260
-
Neuronal vulnerability in Parkinson's disease.Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S52-4. doi: 10.1016/S1353-8020(11)70018-9. Parkinsonism Relat Disord. 2012. PMID: 22166454 Review.
-
Estimating neuron dendritic length in 3D from total vertical projections and from vertical slices.Acta Neurol Scand Suppl. 1992;137:14-9. doi: 10.1111/j.1600-0404.1992.tb05033.x. Acta Neurol Scand Suppl. 1992. PMID: 1414257 Review.
Cited by
-
Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology.Sci Rep. 2016 Jul 27;6:30509. doi: 10.1038/srep30509. Sci Rep. 2016. PMID: 27461410 Free PMC article.
-
Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker.Mov Disord. 2021 Jul;36(7):1592-1602. doi: 10.1002/mds.28531. Epub 2021 Mar 10. Mov Disord. 2021. PMID: 33751655 Free PMC article.
-
Does a prion-like mechanism play a major role in the apparent spread of α-synuclein pathology?Alzheimers Res Ther. 2012 Dec 17;4(6):48. doi: 10.1186/alzrt151. eCollection 2012. Alzheimers Res Ther. 2012. PMID: 23245350 Free PMC article. Review.
-
Pathologic and immunohistochemical findings in hypothalamic and mesencephalic regions in the pah(enu2) mouse model for phenylketonuria.Pediatr Res. 2005 Aug;58(2):283-7. doi: 10.1203/01.PDR.0000170000.78670.44. Epub 2005 Jul 31. Pediatr Res. 2005. PMID: 16055931 Free PMC article.
-
Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson's Disease?Mol Neurobiol. 2022 Feb;59(2):1333-1344. doi: 10.1007/s12035-021-02670-w. Epub 2022 Jan 5. Mol Neurobiol. 2022. PMID: 34984583 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical